Ascendis Pharma AS (ASND)
153.98
+1.67
(+1.10%)
USD |
NASDAQ |
Mar 14, 12:36
Ascendis Pharma Max Drawdown (5Y): 61.72% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Evaxion Biotech AS | -- |
| Novo Nordisk AS | 46.79% |
| Akari Therapeutics PLC | 98.88% |
| Autolus Therapeutics PLC | 96.58% |
| Bicycle Therapeutics PLC | 82.06% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -7.628 |
| Beta (5Y) | 0.6159 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 39.11% |
| Historical Sharpe Ratio (5Y) | 0.0302 |
| Historical Sortino (5Y) | 0.0511 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.60% |